| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 465.239 | 509.243 | 266.707 | 19.447 | 0 | 1.541 | 0 |
| Total Income - EUR | - | - | 0 | 465.239 | 509.674 | 265.766 | 19.386 | 0 | 1.576 | 0 |
| Total Expenses - EUR | - | - | 686 | 35.359 | 212.002 | 201.002 | 86.829 | 11.692 | 12.837 | 1.802 |
| Gross Profit/Loss - EUR | - | - | -686 | 429.880 | 297.672 | 64.764 | -67.442 | -11.692 | -11.261 | -1.802 |
| Net Profit/Loss - EUR | - | - | -686 | 425.227 | 294.113 | 62.364 | -67.637 | -11.692 | -11.261 | -1.802 |
| Employees | - | - | 1 | 1 | 11 | 7 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Norofert Fitofarma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 97 | 456.560 | 1.033.442 | 1.052.926 | 834.219 | 686.177 | 679.190 | 671.782 |
| Inventories | - | - | 0 | 8.922 | 43.208 | 58.600 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 447.781 | 990.091 | 975.885 | 833.823 | 684.546 | 679.003 | 671.694 |
| Cash | - | - | 97 | -144 | 143 | 18.440 | 396 | 1.631 | 187 | 88 |
| Shareholders Funds | - | - | -642 | 424.597 | 714.660 | 763.475 | 678.908 | 669.322 | 656.032 | 650.563 |
| Social Capital | - | - | 44 | 43 | 4.215 | 4.135 | 4.043 | 4.056 | 4.043 | 4.021 |
| Debts | - | - | 739 | 31.963 | 318.782 | 289.450 | 155.336 | 16.871 | 23.158 | 21.219 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4675 - 4675" | |||||||||
| CAEN Financial Year |
4675
|
|||||||||
Comments - Norofert Fitofarma S.r.l.